Referenslitteratur för:

Referenslitteratur för produkten Femal och indikationen PMS
 
  FÖRFATTARE OCH TIDSKRIFT
PUBLICERAD
HÄMTA PDF
       
  Referenser till den aktuella webb-sidan    
       
  1. Winther K, Hedman C.
Assessment of the Effects of the Herbal Remedy Femal on the Symptoms of Premenstrual Syndrome.
Current Therapeutic Research 63(5): 344-54; 2002

1990 Hämta här
  2. Rein E, Winther K, Hedman C.
A herbal remedy, Femal, made from pollen extracts, reduces hot flushes and improves quality of life in menopausal women.
Presented as a poster at the 5th International Symposium on Women's Health and Menopause, Florence, Italy, April 21-24, 2004.

 2005
 Hämta här
  3. Winther K, Rein E, Hedman C.
Femal, a herbal remedy made from pollen extracts, reduces hot flushes and improves quality of life in menopausal women: a randomized, placebo-controlled, parallel study.
Climacteric 8: 162-170; 2005

 2005
 Hämta här
  4. Gerhardsen G, Gerhardsen S, Fomitz G, Roos S, Petersen F.
Femal, a natural remedy based on two pollen extracts, reduces symptoms of PMS.
Presentation at the 6th Congress of the European Society of Gynecology,
Helsinki, Finland, June 1-4, 2005.

 2005
 Hämta här
  4. Kimura H, Gruber P.
Perimenopausal symptoms such as hot flushes and mood swings are reduced by a standardised pollen and pistil extracts.
Climacteric 5, Suppl 1, p.85 (abstract); 2002.

 2002 Hämta här
  5. Winther K, Hedman C.
A preparation containing pollen and pistil extracts combined with Royal Jelly reduces PMS and menopausal symptoms.
Climacteric 5, Suppl 1, p.86 (abstract); 2002.

2002
  
  6. Gerhardsen G, Gerhardsen S, Killi M. et al.
The efficacy of femal in the treatment of pre-menstrual syndrome - a double blind. parallel group, placebo controlled, multi-centre study.
Manuscript 2006.
2006
  
       
  Övriga referenser till PMS-studier    
       
  1. Andersch B, Svensson A, Hansson L.
Pre-eclampsia, hypertension and the premenstrual tension syndrome.
Int J Gynaecol Obstet 32(2): 123-7, 1990.

 1990
 Hämta här
  2. Andersch B, Hahn L.
Progesterone treatment of premenstrual tension – a double blind study.
J Psychosom Res 29(5): 489-93; 1985.
 		1985 Hämta här
 

   
  3. Baca-Garcia E, Diaz-Sastre C, Ceverino A, Garcia Resa E, Oquendo MA, Saiz-Riz J, de Leon J:
Premenstrual sytmptoms and luteal suicide attempts.
Eur Arch Psychiatry Clin Neurosci 254(5): 326-9; 2004.

 2004 Hämta här
  4. Basoglu C, Cetin M, Semiz UB, Agargun MY, Ebrinc S.
Premenstrual exacerbation and suicidal behavior in patients with panic disorder.
Compr Psychiatry 41(2): 103-5; 2000.

 2000 Hämta här
  5. Borenstein J, Chiou CF, Dean B, Wong J, Wade S:
Estimating Direct and Indirect Costs of Premenstrual Syndrome.
J Occup Environ Med 47(1): 26-33, 2005.

 2005 Hämta här
  6. Bäckström T, Andersson A, Andree L et al.:
Pathogenesis in menstrual cycle-linked CNS disorders.
Ann NY Acad Sci 1007, 42-53, 2003.

2003 Hämta här
  7. Bäckström T, Andree L, Birzniece V et al.:
The role of hormones and hormonal treatments in premenstrual syndrome.
CNS Drugs 17, 325-42, 2003.

2003 Hämta här
  8. Björn I, Bixo M, Nöjd KS et al.:
The impact of different doses of medroxyprogesterone acetate on mood symptoms in sequential hormonal therapy.
Gynecol Endocrinol 16, 1-8, 2002.

2002

 Hämta här
  9. Bixo M, Allard P, Bäckström T et al.:
Binding of [3H]paroxetine to serotonine uptake sites and of [3H]lysergic acid diethylamide to 5-HT2A receptors in platelets from women with premenstrual dysphoric disorder during gonadotropin releasing hormone treatment.
Psychoneuroendocrinology 26, 551-64; 2001.

2001 Hämta här
  10. Christie S, Walker AF, Hicks SM et al.:
Flavonoid supplement improves leg health and reduces fluid retention in pre-menopausal women in a double-blind, placebo-controlled study.
Phytomedicine 11, 11-7; 2004.
2004
 Hämta här
  11. Domoney CL, Vashisht A, Studd JW:
Premenstrual syndrome and the use of alternative therapies.
Ann NY Acad Sci 997, 320-40; 2003.

2003 Hämta här
  12. Endicott J, McLaughlin TP, Grudzinski AN:
Comparison of managed care charges among patients treated with selective serotonin reuptake inhibitors for premenstrual dysphoric disorder.
J Clin Psychiatry 64, 343-51; 2004.

2003

 

 Hämta här
  13. Eriksson E, Andersch B, Ho HP, Landen M, Sundblad C.
Diagnosis and treatment of premenstrual dysphoria.
J Clin Psychiatry 63, Suppl 7:16-23; 2002.

 2002 Hämta här
  14. Eriksson E, Andersch B, Hoi-Por H, Landén M, Sundblad C:
Serotoninupptagshämmare ger snabb lindring vid premenstruell dysfori.
Läkartidningen 98(34):3524-30; 2001.

 2001 Hämta här
  15. Eriksson E, Hedberg MA, Andersch B, Sundblad C.
The serotonin reuptake inhibitor paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome.
Neuropsychopharmacology 12(2): 167-76; 1995.

 1995 Hämta här
  16. Eriksson E, Alling C, Andersch B, Andersson K, Berggren U.
Cerebrospinal fluid levels of monoamine metabolites. A preliminary study of their relation to menstrual cycle phase, sex steroids, and pituitary hormones in healthy women and i women with premenstrual syndrome.
Neuropsychopharmacology 11(3): 201-13; 1994.

 1994 Hämta här
  17. Eriksson E, Sundblad C, Lisjo P, Modigh K, Andersch B.
Serum levels of androgens are higher in women with premenstrual irritability and dysphoria than in controls.
Psychoneuroendocrinology 17(2-3): 195-204; 1992.

 1992 Hämta här
  18. Freeman EW, Rickels K, Sondheimer SJ et al.:
Continuous or intermittent dosing with sertraline for patients with severe premenstrual syndrome or premenstrual dysphoric disorder.
Am J Psychiatry 161:1511-6; 2003.

2004
 Hämta här
  19. Freeman EW.
Premenstrual syndrome and premenstrual dysphoric disorder: definitions and diagnosis.
Psychoneuroendocrinology 28, suppl. 3: 25-37, 2003.

2003
 Hämta här
  20. Halbreich U, Kahn LS.
Treatment of premenstrual dysphoric disorder with luteal phase dosing of sertraline.
Expert Opin Pharmacother 4(11):2065-78, 2003.
2003 Hämta här
  21. Halbreich U, Borenstein J, Pearlstein T, Kahn LS.
The prevalence, impairment, impact, and burden of premenstrual dysphoric
disorder (PMS/PMDD).
Psychoneuroendocrinoligy  28, suppl. 3: 1-23, 2003.

2003
 Hämta här
  22. Halbreich U
The etiology, biology, and evolving pathology of premenstrual syndromes.
Pxychoneuroendocrinology  28, suppl. 3:55-99; 2003.

2003 Hämta här
  23. Hsiao CC, Liu CY, Hsiao MC:
No correlation of depression and anxiety to plasma estrogen and progesterone levels in patients with premenstrual dysphoric disorder.
Psychiatry Clin Neurosci 58(6): 595-9; 2004.

 2004 Hämta här
  24. Landen M, Eriksson O, Sundblad C, Andersch B, Naessen T, Eriksson E.
Compounds with affinity for serotonergic receptors in the treatment of premenstrual dysphoria: a comparison of buspirone, nefazodone and placebo.
Psychopharmacology (Berl). 155(3): 292-8; 2001.

 2001 Hämta här
  25. Levin AM.
Premenstrual syndrome: a new concept in its pathogenesis and treatment.
Med Hypotheses 62(1): 130-2; 2004.

2004 Hämta här
  26. Rapkin A.  
A review of treatment of premenstrual syndrome and premenstrual dysphoric disorder.
Psychoneuroendocrinology 28, suppl. 3: 39-53; 2003.

2003
 Hämta här
  27. Sundblad C, Wikander I, Andersch B, Eriksson E.
A naturalistic study of paroxetine in premenstrual syndrome: efficacy and side-effects during ten cycles of treatment.
Eur Neuropsychopharmacol 7(3): 201-6; 1997.

 1997 Hämta här
  28. Sundblad C, Modigh K, Andersch B, Eriksson E.
Clomipramine effectively reduces premenstrual irritability and dysphoria: a placebo-controlled trial.
Acta Psychiatr Scand 85(1): 39-47; 1992.

1992 Hämta här
  29. Terman A, Brunk UT.
The effect of Polbax extract on lipofuscin accumulation in cultured neonatal rat cardiac myocytes.
Phytother Res   16:180-2; 2002.

2002 Hämta här
  30. Wikander I, Sundblad C, Andersch B, Dagnell I, Zylberstein D, Bengtsson F, Eriksson E.
Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle?
J Clin Psychopharmacol 18(5): 390; 1998.

 1998 Hämta här
 

31. Yonkers KA, Perlstein T, Rosenheck RA.
Premenstrual disorders: bridging research and clinical reality.
Arch Women Ment Health 6 (4): 287-92; 2003.

 2003 Hämta här